Oxbow Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $428K | Buy |
|
|||||
|
2023
Q4 | $419K | Sell |
|
|||||
|
2023
Q3 | $5.02M | Buy |
|
|||||
|
2023
Q2 | $714K | Buy |
|
|||||
|
2023
Q1 | $769K | Sell |
|
|||||
|
2022
Q4 | $979K | Buy |
|
|||||
|
2022
Q3 | $836K | Sell |
|
|||||
|
2022
Q2 | $1.24M | Sell |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $1.63M | Buy |
|
|||||
|
2021
Q3 | $1.19M | Buy |
|
|||||
|
2021
Q2 | $991K | Sell |
|
|||||
|
2021
Q1 | $9.42M | Sell |
|
|||||
|
2020
Q4 | $11M | Sell |
|
|||||
|
2020
Q3 | $10.9M | Sell |
|
|||||
|
2020
Q2 | $9.97M | Buy |
|
|||||
|
2020
Q1 | $3.99M | Sell |
|
|||||
|
2019
Q4 | $4.84M | Sell |
|
|||||
|
2019
Q3 | $4.57M | Buy |
|
|||||
|
2019
Q2 | $5.2M | Buy |
|
|||||
|
2019
Q1 | $5.03M | Sell |
|
|||||
|
2018
Q4 | $5.4M | Sell |
|
|||||
|
2018
Q3 | $10.8M | Sell |
|
|||||
|
2018
Q2 | $9.03M | Buy |
|
|||||
|
2018
Q1 | $8.78M | Buy |
|
|||||
|
2017
Q4 | $8.78M | Sell |
|
|||||
|
2017
Q3 | $8.75M | Sell |
|
|||||
|
2017
Q2 | $11.8M | Buy |
|
|||||
|
2017
Q1 | $11.9M | Sell |
|
|||||
|
2016
Q4 | $11.4M | Sell |
|
|||||
|
2016
Q3 | $12.2M | Sell |
|
|||||
|
2016
Q2 | $13M | Sell |
|
|||||
|
2016
Q1 | $11.8M | Buy |
|
|||||
|
2015
Q4 | $2.51M | Sell |
|
|||||
|
2015
Q3 | $2.5M | Buy |
|
|||||
|
2015
Q2 | $2.4M | Buy |
|
|||||
|
2015
Q1 | $2.24M | Sell |
|
|||||
|
2014
Q4 | $2.14M | Sell |
|
|||||
|
2014
Q3 | $2.06M | Sell |
|
|||||
|
2014
Q2 | $2.07M | Buy |
|
|||||
|
2014
Q1 | $2.23M | Buy |
|
|||||
|
2013
Q4 | $2.11M | Buy |
|
|||||
|
2013
Q3 | $1.92M | Buy |
|
|||||
|
2013
Q2 | $1.44M | Buy |
|